Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

Interleukin-12 (IL-12) is a potent immunotherapeutic agent.

Guardado en:
Detalles Bibliográficos
Autores principales: Pengju Wang, Xiaozhu Li, Jiwei Wang, Dongling Gao, Yuenan Li, Haoze Li, Yongchao Chu, Zhongxian Zhang, Hongtao Liu, Guozhong Jiang, Zhenguo Cheng, Shengdian Wang, Jianzeng Dong, Baisui Feng, Louisa S. Chard, Nicholas R. Lemoine, Yaohe Wang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/84f37118338744888cbe6343b27f3c3f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares